Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
The Chain: Protein Engineering Podcast
Cambridge Healthtech Institute
uyfljlhjlkjgghlkjgjklgl
the master
Native Land Pod
iHeartPodcasts and Reasoned Choice
The Micah Hanks Program
Micah Hanks
Blurry Creatures
Blurry Creatures
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
Pursuit of the Paranormal
Ash and Greg
Soundings
KVMR-FM
My Weird Prompts
Daniel Rosehill
Firing & Wiring
Interocept Labs
Veränderungskatalysator
Jasmin Schweiger
HAB gehört
Herzog August Bibliothek Wolfenbüttel
UEG Podcast
UEG United European Gastroenterology
You’re Probably Right
Murray Ed
No Lights Paranormal
No Lights Paranormal
Acid Horizon
Acid Horizon
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Podcast Agro Pintar
Choon Kiat Lim
Weathered Questions
Jan Ryherd & Kaj O'Mara
Unbuffered
Institute for Local Self-Reliance
TED-Ed
TED-Ed
Accidental Gods
Accidental Gods
Wildly Unplug
Lauren Connolly
Women Over 70: Aging Reimagined
Gail Zelitzky and Catherine Marienau
Aha! Zehn Minuten Alltags-Wissen
WELT
Atomic Anesthesia
Rhea Temmermand, PhD, CRNA & Sachi Lord, MSN, CRNA
UAP Files Podcast
UAP Files Podcast
Heliox: Where Evidence Meets Empathy 🇨🇦
by SC Zoomers
Room to Think
Lyssia Katan
Come explore the paranormal files as we delve into the unexplained. The paranormal podcast.
Matt Harvey | Amanda Harvey Paranormal Experts
Referential
Dr. Khaliden Nas
Radiowissen
Bayerischer Rundfunk
Warden's Watch
Wayne Saunders / John Nores
The Long Run with Luke Timmerman
Timmerman Report
Sasquatch Experience
Anomalis Entertainment, LLC
The Automated Daily - Space News Edition
TrendTeller
Paranormal UK Radio Network
Paranormal UK Radio Network
Science
Cambridge Healthtech Institute
July 14, 2026 | Most ADCs today lean on the same Topo-1 payloads—and resistance is catching up. Jack Elands, Ph.D., founder and CEO of Adcytherix, speaks with host Rakesh Dixit, Ph.D. about what “next-generation ADCs” sh...
At this year’s PEGS Boston, industry experts gathered on a panel to explore how AI and machine learning are deployed in biologics R&D today. Moderated by Peter M. Tessier, Ph.D., Albert M. Mattocks professor of pharmaceu...
May 12, 2026 | When it comes to drug discovery, either you find a rare, clean target and everything clicks, or you spend a decade chasing biology that refuses to cooperate. Daniel Chen, M.D., Ph.D., founder and CEO of Sy...
How is BindCraft, the automated pipeline for de novo protein binder design, changing the protein design industry? Martin Pacesa, assistant professor of pharmacology at the University of Zurich, joins The Chain to discuss...
T cell and immune cell engagement is gaining traction, but what makes it different from other therapies? Patrick Baeuerle, Ph.D., chief scientific advisor at Cullinan Therapeutics, and Jeffrey Miller, M.D., deputy direct...
During last year’s PEGS Europe, industry experts gathered on a panel to discuss the future of biologic therapeutics. The panel kicked off with a presentation on 50 years of monoclonals, from hybridomas to next-gen antibo...
How has immunotherapy evolved in the last decade? In this episode of The Chain, Laszlo Radvanyi, professor of immunology at the University of Toronto, discusses his years-long research on cancer immunotherapy, including ...
December 13, 2025 | What is next for immunogenicity? In this episode of The Chain, Vibha Jawa, chief scientific officer at EpiVax, provides her thoughts and insights on BiTE molecules, pegylated molecules, and other biol...
November 11, 2025 | What is the next modality to focus on in the next 10 years? For Bahija Jallal, CEO of Immunocore, it would be T-cell engagers. In this episode of The Chain, host Rakesh Dixit speaks with Jallal on the...
As drug development pushes into more complex antibody formats, the big question is: how do you really assess developability? In this episode, host Nimish Gera speaks with Shamit Shrivastava, Ph.D., founder and CEO of Apo...
September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and au...
August 12, 2025 | Diagonal Therapeutics founder and CEO Alexey Lugovskoy discusses the key lessons learned over his illustrious career, starting from his childhood in the Soviet Union to founding his own company, Diagona...
July 15, 2025 | Are licensing fees required or gatekeeping? In this episode of The Chain, host Nimish Gera, vice president of Biologics at Mythic Therapeutics, and Ian Wilkinson, CEO of Gamma Proteins, discuss accessing ...
June 10, 2025 | In this bonus episode of The Chain, Daniel Chen, MD, PhD, founder and CEO of Synthetic Design Lab, returns for the Science Commune segment and speaks with Keith Flaherty, MD, FAACR, professor of Medicine ...
June 10, 2025 | This episode of The Chain features a panel discussion from May’s PEGS Boston. Moderated by Peter Tessier, Albert M. Mattocks professor of Pharmaceutical Sciences and Chemical Engineering at the University...
In this episode of The Chain, host Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC, talks with Pamela Barney, former associate director of HR, AbbVie, about her career within biotech/pharma organizations and some key les...
In this episode of The Chain, host Brandon DeKosky, associate professor, speaks with MIT colleague Jessica Stark, Underwood-Prescott career development professor, about glycans and why they are important in cancer resear...
March 11, 2025 | In this episode of The Chain, host Andrew Buchanan, principal scientist at AstraZeneca, and Andreas Plückthun, professor and head of biochemistry at the University of Zurich, discuss AI/ML technologies i...
February 21, 2025 | This episode marks the 50th anniversary of one of the most influential papers in biomedical science—the 1975 Milstein and Köhler paper on hybridoma technology, which paved the way for monoclonal antib...
In this episode of The Chain, host Andrew Bradbury, CSO of Specifica, an IQVIA business, speaks with Randolph Lopez, CTO and co-founder of A-Alpha Bio, about how A-Alpha Bio is changing the game of protein-protein intera...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.